Trial intelligence / Profile preview

Pimecrolimus versus ketoconazole for seborrheic dermatitis

2005-006208-21Phase 3Active

Sponsor
Department of Dermatology, University of Kiel
Start
Aug 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in seborrheic dermatitis (SD) comparing Pimecrolimus cream with Ketoconazole cream control (2 arms). Started Aug 2006; status: active.

02

Drugs

pimecrolimusketoconazole
03

Conditions

seborrheic dermatitis (SD)

Beyond the preview

Go deeper on 2005-006208-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-006208-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call